175 related articles for article (PubMed ID: 29105189)
61. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.
Starzl TE; Demetris AJ; Murase N; Thomson AW; Trucco M; Ricordi C
Trends Pharmacol Sci; 1993 May; 14(5):217-23. PubMed ID: 8212319
[TBL] [Abstract][Full Text] [Related]
62. Editorial: Kidney Transplantation and Innate Immunity.
Pontrelli P; Grandaliano G; Van Kooten C
Front Immunol; 2020; 11():603982. PubMed ID: 33154759
[No Abstract] [Full Text] [Related]
63. Immunosuppressive effects of cyclophosphamide and L-asparaginase in the inbred rat renal transplant model.
Levin B; Merrill JP
Transplantation; 1972 Feb; 13(2):160-3. PubMed ID: 4550990
[No Abstract] [Full Text] [Related]
64. Utilization of Mesenchymal Stem Cells in Kidney Transplantation: From Bench to Bedside.
Saidi RF; Moghadasali R; Shekarchian S
Iran J Kidney Dis; 2019 Jul; 13(4):213-224. PubMed ID: 31422386
[TBL] [Abstract][Full Text] [Related]
65. Cyclophosphamide 200 mg/kg lacks ability to induce pluripotent stem cell engraftment in mice.
Yoshikawa M; Tomita Y; Uchida T; Zhang QW; Shimizu I; Nomoto K
Transplant Proc; 1999 Aug; 31(5):1939. PubMed ID: 10455924
[No Abstract] [Full Text] [Related]
66. Immunosuppressive drugs and the induction of transplantation tolerance.
Thomson AW
Transpl Immunol; 1994 Dec; 2(4):263-70. PubMed ID: 7535641
[No Abstract] [Full Text] [Related]
67. Novel immunosuppressive agents in tolerance induction.
Krieger NR; Knechtle SJ
Curr Drug Targets Cardiovasc Haematol Disord; 2002 Dec; 2(2):97-103. PubMed ID: 12769651
[TBL] [Abstract][Full Text] [Related]
68. Donor cell chimerism permitted by immunosuppressive drugs: a new view of organ transplantation.
Starzl TE; Demetris AJ; Murase N; Thomson AW; Trucco M; Ricordi C
Immunol Today; 1993 Jun; 14(6):326-32. PubMed ID: 8397774
[TBL] [Abstract][Full Text] [Related]
69. Long-term cyclophosphamide treatment for recurrent type I membranoproliferative glomerulonephritis after transplantation.
Lien YH; Scott K
Am J Kidney Dis; 2000 Mar; 35(3):539-43. PubMed ID: 10692284
[TBL] [Abstract][Full Text] [Related]
70. Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity.
Chatenoud L
Curr Opin Organ Transplant; 2009 Aug; 14(4):351-6. PubMed ID: 19610168
[TBL] [Abstract][Full Text] [Related]
71. Combined kidney and hematopoeitic cell transplantation to induce mixed chimerism and tolerance.
Lowsky R; Strober S
Bone Marrow Transplant; 2019 Aug; 54(Suppl 2):793-797. PubMed ID: 31431706
[TBL] [Abstract][Full Text] [Related]
72. Synergistic effect of short-term fractionated lymphoid irradiation with initial high doses of FK506 on the induction of tolerance to kidney allografts in dogs.
Watanabe K; Endo T; Koshiba K; Sato K; Kakita A; Maruyama S; Masaki Y
Transplant Proc; 1998 Feb; 30(1):9-11. PubMed ID: 9474940
[No Abstract] [Full Text] [Related]
73. Immunobiology and immunopharmacology of organ allograft rejection.
Suthanthiran M; Strom TB
J Clin Immunol; 1995 Jul; 15(4):161-71. PubMed ID: 7593462
[TBL] [Abstract][Full Text] [Related]
74. Transplantation without immunosuppression: what the future may hold.
Orosz CG
Cleve Clin J Med; 1999; 66(7):395-6. PubMed ID: 10410437
[TBL] [Abstract][Full Text] [Related]
75. Cellular therapies in kidney transplantation.
Leclerc S; Lamarche C
Curr Opin Nephrol Hypertens; 2021 Nov; 30(6):584-592. PubMed ID: 34412086
[TBL] [Abstract][Full Text] [Related]
76. Prospects for induction of tolerance in renal transplantation.
Krensky AM; Clayberger C
Pediatr Nephrol; 1994 Dec; 8(6):772-9. PubMed ID: 7696124
[TBL] [Abstract][Full Text] [Related]
77. Renal transplantation.
Ramanathan V; Goral S; Helderman JH
Semin Nephrol; 2001 Mar; 21(2):213-9. PubMed ID: 11245782
[TBL] [Abstract][Full Text] [Related]
78. The role of genetics in drug dosing.
Ware N
Pediatr Nephrol; 2012 Sep; 27(9):1489-98. PubMed ID: 22358188
[TBL] [Abstract][Full Text] [Related]
79. Immunosuppressive therapy protocols in kidney transplantation in adults.
Karamehić J; Lorber M; Formica R; Gavrankapetanović F; Heljić B; Subasić D; Zecević L
Bosn J Basic Med Sci; 2006 Aug; 6(3):43-7. PubMed ID: 16995847
[TBL] [Abstract][Full Text] [Related]
80. Development and validation of the first consensus gene-expression signature of operational tolerance in kidney transplantation, incorporating adjustment for immunosuppressive drug therapy.
Christakoudi S; Runglall M; Mobillo P; Rebollo-Mesa I; Tsui TL; Nova-Lamperti E; Taube C; Norris S; Kamra Y; Hilton R; Augustine T; Bhandari S; Baker R; Berglund D; Carr S; Game D; Griffin S; Kalra PA; Lewis R; Mark PB; Marks SD; MacPhee I; McKane W; Mohaupt MG; Paz-Artal E; Kon SP; Serón D; Sinha MD; Tucker B; Viklický O; Stahl D; Lechler RI; Lord GM; Hernandez-Fuentes MP
EBioMedicine; 2020 Aug; 58():102899. PubMed ID: 32707447
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
